SCHEMBL25777809

SCHEMBL25777809

N#Cc1c(-c2ccccc2-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cccc1-c1ccccc1-c1nc(-c2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 8/20 0.50
▸ ADORA2A P29274 7/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ ADORA3 P0DMS8 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ ADORA2B P29275 1/20 0.44
▸ SQOR Q9Y6N5 2/20 0.43
▸ L3MBTL1 Q9Y468 3/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HPGD P15428 4/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25774872 1.00 ADORA1 (0.50) ADORA1ADORA2AHSD17B10KMT2AMEN1
SCHEMBL26553068 0.97 ADORA1 (0.47) ADORA1ADORA2AHSD17B10KMT2AMEN1
SCHEMBL25774837 0.95 ADORA1 (0.46) ADORA1ADORA2AHSD17B10KMT2AMEN1
SCHEMBL26553166 0.95 ADORA1 (0.46) ADORA1ADORA2AHSD17B10KMT2AMEN1
SCHEMBL26553155 0.95 ADORA1 (0.46) ADORA1ADORA2AHSD17B10KMT2AMEN1
SCHEMBL26553418 0.93 ADORA1 (0.53) ADORA1ADORA2AHSD17B10KMT2AMEN1
SCHEMBL26553152 0.92 ADORA2A (0.44) ADORA1ADORA2AHSD17B10KMT2AMEN1
SCHEMBL25774874 0.92 ADORA2A (0.44) ADORA1ADORA2AHSD17B10KMT2AMEN1
SCHEMBL26553310 0.89 ADORA2A (0.48) ADORA1ADORA2AHSD17B10KMT2AMEN1
SCHEMBL25777807 0.87 ADORA1 (0.51) ADORA1ADORA2AHSD17B10KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2023-10-19 — — US disclosed
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2023-10-19 — — US disclosed
EP-4206195-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME Lg Chem, Ltd. (KR) 2023-07-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331704-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME NR2E3, NR2E1, NR0B2 ADORA1 353/4885ADORA2A 1443/4885HSD17B10 2403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback